Intrauterine contraceptive devices and risk of pelvic inflammatory disease: Standard of care in high STI prevalence settings

Reproductive Health Matters

Volumn 12, Issue 23, 2004, Pages 136-143

  Steen, Richard ^a   Shapiro, Katharine ^a  

^a STI Control and Reproductive Health   (Switzerland)

Author keywords

chlamydia; ectopic pregnancy; gonorrhoea; infertility; intrauterine contraceptive device; pelvic inflammatory disease; sexually transmitted infection; standard of care

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; DOXYCYCLINE;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC THERAPY; CHLAMYDIASIS; COST BENEFIT ANALYSIS; DRUG EFFICACY; ECTOPIC PREGNANCY; FEMALE INFERTILITY; GONORRHEA; HEALTH CARE ORGANIZATION; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; INTRAUTERINE CONTRACEPTIVE DEVICE; PELVIC INFLAMMATORY DISEASE; PREGNANCY; PREVALENCE; PRIORITY JOURNAL; REPRODUCTIVE HEALTH; REVIEW; RISK ASSESSMENT; SAFETY; SCREENING; SEXUALLY TRANSMITTED DISEASE;

EID: 2442464794     PISSN: 09688080     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-8080(04)23123-8     Document Type: Article

References (30)

1. An extremely low-cost option: IUCD Method Brief No. 3. 2003;Kenya Ministry of Health, Nairobi
2. Washington AE, Aral SO, Wolner-Hanssen P Assessing risk for pelvic inflammatory disease and its sequelae. JAMA. 266:1991;2581-2586
3. Grimes DA Intrauterine device and upper-genital-tract infection. Lancet. 356(9234):2000;1013-1019
4. Coggins C, Sloan NL Prophylactic antibiotics before insertion of intrauterine devices [Comment]. Lancet. 351(9120):1998;1962-1963
5. Dallabetta GA, Gerbase AC, Holmes KK Problems, solutions, and challenges in syndromic management of sexually transmitted diseases. Sexually Transmitted Infections. 74(Suppl.1):1998;S1-S11
6. Increasing Access to the IUD: An Inter-Agency Workshop organized by Family Health International's Research to Practice Initiative in collaboration with USAID's Service Delivery Improvement Division. 2003;FHI, Chapel Hill NC
7. Expanding Women's Contraceptive Choices: IUCD Method Brief No. 1. 2003;Kenya Ministry of Health, Nairobi
8. Improving Access to Quality Care in Family Planning. Medical Eligibility Criteria for Contraceptive Use. 2nd ed. WHO/RHR/00.02. 2000;World Health Organization, Geneva. At: 〈http://www.who.int/reproductive_health/ publications/RHR_002_medical_eligibility_criteria_second_edition〉
9. World Contraceptive Use. 2001;UN Population Division, Department of Economic and Social Affairs, New York
10. Walsh TL, Grimes DA, Frezieres R, et al. Randomized controlled trial of prophylactic antibiotics before insertion of intrauterine devices. IUD Study Group. Lancet. 351:1998;1005-1008
11. Sinei SK, Schulz KF, Lamptey PR, et al. Preventing IUCD-related pelvic infection: the efficacy of prophylactic doxycycline at insertion. British Journal of Obstetrics & Gynaecology. 97(5):1990;412-419
12. Sinei SK, Morrison CS, Sekadde-Kigondu C, et al. Complications of use of intrauterine devices among HIV-1-infected women. Lancet. 351:1998;1238-1241
13. Ladipo OA, Farr G, Otolorin E, et al. Prevention of IUD-related pelvic infection: the efficacy of prophylactic doxycycline at IUD insertion. Advances in Contraception. 7(1):1991;43-54
14. Weström L, Eschenbach D Pelvic inflammatory disease. Holmes KK, Sparling PF, Mårdh P-A, et al. Sexually Transmitted Diseases. 1999;783-809 McGraw-Hill, New York
15. AbouZahr C, Åhman E, Guidotti R Puerperal sepsis and other puerperal infections. Murray CJL, Lopez AD Health Dimensions of Sex and Reproduction. 1998;Harvard School of Public Health, Boston
16. Ferraz do Lago R, Simoes JA, Bahamondes L, et al. Follow-up of users of intrauterine devices with and without bacterial vaginosis and other cervicovaginal infections. Contraception. 68:2003;105-109
17. Shelton JD Risk of clinical pelvic inflammatory disease attributable to an intrauterine device. Lancet. 357(9254):2001;443
18. Lu R, Wang N, Zhao J Investigation of intrauterine microbes after intrauterine operation [in Chinese]. Chung-Hua Fu Chan Ko Tsa Chih (Chinese Journal of Obstetrics & Gynecology). 33(3):1998;168-169
19. Paavonen J Pelvic inflammatory disease. From diagnosis to prevention. Dermatologic Clinics. 16(4):1998;747-756
20. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines. MMWR - Morbidity & Mortality Weekly Report 2002;51
21. Gareen IF, Greenland S, Morgenstern H Intrauterine devices and pelvic inflammatory disease: meta-analyses of published studies, 1974-1990. Epidemiology. 11(5):2000;589-597
22. Farley TM, Rosenberg MJ, Rowe PJ, et al. Intrauterine devices and pelvic inflammatory disease: an international perspective [Comment]. Lancet. 339(8796):1992;785-788
23. Wright EA, Aisien AO Pelvic inflammatory disease and the intrauterine contraceptive device. International Journal of Gynecology & Obstetrics. 28(2):1989;133-136
24. Cohen MS, Henderson GE, Aiello P, et al. Successful eradication of sexually transmitted diseases in the People's Republic of China: implications for the 21st century. Journal of Infectious Diseases. 174(Suppl.2):1996;S223- S229
25. Morrison CS, Sekadde-Kigondu C, Miller WC, et al. Use of sexually transmitted disease risk assessment algorithms for selection of intrauterine device candidates. Contraception. 59:1999;97-106
26. Grimes DA, Schulz KF. Antibiotic prophylaxis for intrauterine contraceptive device insertion. Cochrane Database of Systematic Reviews 2001(1).
27. World Health Organization Guidelines for the Management of Sexually Transmitted Infections. WHO/HIV_AIDS/2001.01, WHO/RHR/01.10. 2001;WHO, Geneva
28. Meheus A Women's health: importance of reproductive tract infections, pelvic inflammatory disease and cervical cancer. Germain A, Holmes KK, Piot P, et al. Reproductive Tract Infections: Global Impact and Priorities for Women's Reproductive Health. 1992;Plenum Press, New York
29. World Health Organization Investing in Health Research and Development: Report of the Ad Hoc Committee on Health Research Relating to Future Intervention Options. 1996;WHO, Geneva
30. Villar J, Carroli G, Gülmezoglu AM The gap between evidence and practice in maternal healthcare. International Journal of Gynecology and Obstetrics. 75:2001;S47-S54